February 21, 2019
Mayo Clinic finds better way to reprogram stem cells
Post-Bulletin by Anne Halliwell “If we’re going to successfully use reprogrammed stem cells to treat patients in the clinic, we need to ensure that they are safe and effective, that is, not prone to the risk of mutation and potential tumors,” Dr. Patricia Devaux, a Mayo Clinic molecular scientist and senior author of the article, […]
Tags: Dr. Patricia Devaux, Induced pluripotent stem cells, Post Bulletin, regenerative medicine